Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
0.6403
-0.0698 (-9.83%)
At close: Nov 13, 2026, 4:00 PM EST
0.6440
+0.0037 (0.58%)
After-hours: Nov 13, 2026, 4:34 PM EST

Bio Green Med Solution Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.230.750.040.42--
Revenue Growth
2658.03%1637.21%-89.76%---
Gross Profit
-0.35-0.67-6.52-18.3--
Operating Income
-3.16-8.43-12-25.45-27.66-22.39
Net Income
-11.26-14.09-11.21-22.76-21.4-18.66
Earnings Per Share
-2.01-6.45-502.46---
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3.453.513.143.3818.3536.56
Total Debt
-0.02-0.040.110.03
Net Cash (Debt)
3.453.493.143.3418.2436.53
Net Cash Growth
-9.89%11.09%-6.11%-81.68%-50.07%12.92%
Net Cash Per Share
0.621.59140.58---

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--4.77-7.99-16.11-20.83-18.54
Capital Expenditures
----0.01-0.01-0.03
Free Cash Flow
--4.77-7.99-16.12-20.83-18.57
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-15.80%-90.09%----
Operating Margin
-141.27%-1128.11%-27916.28%-6060.24%--
Pretax Margin
109.31%-400.40%-27893.02%-6083.57%--
Profit Margin
-504.07%-1886.48%-26074.42%-5418.10%--
FCF Margin
--638.55%-18581.40%-3837.62%--

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.909.7154.986.48--